As of today (2024-05-08), Zynex's share price is $10.88.
Zynex's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.48. Hence, Zynex's Price-to-Free-Cash-Flow Ratio for today is 22.81.
The historical rank and industry rank for Zynex's Price-to-Free-Cash-Flow or its related term are showing as below:
ZYXI'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 2.84 Med: 21.22 Max: 381.82
Current: 22.82
During the past 13 years, Zynex's highest Price-to-Free-Cash-Flow Ratio was 381.82. The lowest was 2.84. And the median was 21.22.
ZYXI's Price-to-Free-Cash-Flow is ranked worse than 56.9% of 58
companies
in the Medical Distribution industry
Industry Median: 21.75
vs ZYXI: 22.82
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Zynex was 35.50% per year.
During the past 13 years, Zynex's highest 3-Year average Free Cash Flow per Share Growth Rate was 181.10% per year. The lowest was -92.30% per year. And the median was 40.75% per year.
Zynex Price-to-Free-Cash-Flow Historical Data
The historical data trend for Zynex's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Zynex's Price-to-Free-Cash-Flow
For the Medical Distribution subindustry, Zynex's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zynex's Price-to-Free-Cash-Flow Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Zynex's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Zynex's Price-to-Free-Cash-Flow falls into.
Zynex Price-to-Free-Cash-Flow Calculation
Zynex's Price-to-Free-Cash-Flow ratio for today is calculated as
Zynex's Share Price of today is $10.88. Zynex's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.48.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Zynex Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Zynex's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. it also develops and markets medical devices for non-invasive cardiac monitoring, the products of which are under development. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZYXI has been successfully added to your 